F2R and neoplasm: According to the results of our molecular experiments, our observed anti-tumor effects upon doxycycline treatment and our pathological analysis experiments, we further identified and characterized a critical role for PAR1 in tumor cells, and we show evidence that doxycycline should be treated as a targeted drug for clinical applications.